Science Explorer Back to mapMap

Most cited papers from National Health Service

What are the most cited papers from National Health Service?

The most cited paper from National Health Service is "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls" (Paul R. Burton et al., 2007), with 9,692 citations. Next come "A map of human genome variation from population-scale sequencing" (8,156) and "Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015" (6,333).

Showing 50 of 59 papers. Every paper with more than 1,364 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Paul R. Burton et al. · Nature Open access276 authors 6 Jun 2007 9,692
2 A map of human genome variation from population-scale sequencing Richard M. Durbin et al. · Nature Open access337 authors 26 Oct 2010 8,156
3 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 Christina Fitzmaurice et al. · JAMA Oncology Open access185 authors 5 Dec 2016 6,333
4 A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population Alex Bernard Haynes, Thomas G. Weiser, William R. Berry et al. · New England Journal of Medicine Open access 14 Jan 2009 5,713
5 Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer Martine J Piccart et al. · New England Journal of Medicine Open access 20 Oct 2005 5,138
6 Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Shaun Purcell et al. · Nature Open access Jul 2009 5,082
7 Gastric cancer Elizabeth Catherine Smyth, Magnus Nilsson, Heike Irmgard Grabsch et al. · The Lancet Aug 2020 5,024
8 The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer Peter Goldstraw et al. · Journal of Thoracic Oncology Open access152 authors 2016 4,749
9 Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma Caroline Robert et al. · New England Journal of Medicine 5 Jun 2011 4,523
10 Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010 Valery L. Feigin, Mohammad Hossein Forouzanfar, Rita Krishnamurthi et al. · The Lancet Open access 24 Oct 2013 3,977
11 Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies Marco Solmi, Joaquim Raduà, Miriam Olivola et al. · Molecular Psychiatry ReviewOpen access 2 Jun 2021 3,868
12 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Frank H J van den Hoogen et al. · Arthritis & Rheumatism Open access 3 Oct 2013 3,458
13 Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer Alice Tsang Shaw et al. · New England Journal of Medicine Open access Jun 2013 3,429
14 Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Denise H. Harold et al. · Nature Genetics Open access 6 Sep 2009 3,422
15 Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer Babak Ehteshami Bejnordi et al. · JAMA Open access 12 Dec 2017 3,405
16 Pain: a review of three commonly used pain rating scales Amelia Williamson, Barbara Hoggart · Journal of Clinical Nursing Open access 30 Jun 2005 3,122
17 Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index MAGIC et al. · Nature Genetics Open access376 authors 10 Oct 2010 2,999
18 Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Stuart H. Cohen, Dale N. Gerding, Stuart Johnson et al. · Infection Control and Hospital Epidemiology 22 Mar 2010 2,955
19 PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies Robert F. Wolff, Karel G.M. Moons, Richard D Riley et al. · Annals of Internal Medicine Open access 31 Dec 2018 2,929
20 Prospective Identification of Tumorigenic Prostate Cancer Stem Cells Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research Dec 2005 2,826
21 Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations Jimmy Z. Liu et al. · Nature Genetics Open access 20 Jul 2015 2,805
22 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 Christina Fitzmaurice et al. · JAMA Oncology Open access628 authors 27 Sep 2019 2,699
23 Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci André Franke et al. · Nature Genetics Open access 21 Nov 2010 2,592
24 Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine 9 Feb 2011 2,567
25 Genomic atlas of the human plasma proteome Benjamin B. Sun et al. · Nature Open access 29 May 2018 2,496
26 Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes Daniel Shu Wei Ting et al. · JAMA Open access 12 Dec 2017 2,445
27 Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer David Cunningham, Naureen Starling, Sheela Rao et al. · New England Journal of Medicine 2 Jan 2008 2,326
28 International consensus report on the investigation and management of primary immune thrombocytopenia Drew Provan et al. · Blood Open access 21 Oct 2009 2,283
29 Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer Sarah‐Jane Dawson, Dana W.Y. Tsui, Muhammed Murtaza et al. · New England Journal of Medicine Open access 13 Mar 2013 2,250
30 Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy George Du Toit, Graham Roberts, Peter H. Sayre et al. · New England Journal of Medicine Open access 23 Feb 2015 2,246
31 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Josée Dupuis et al. · Nature Genetics Open access263 authors 17 Jan 2010 2,239
32 A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation Bonnie W. Ramsey, Jane Carolyn Davies, Noel Gerard McElvaney et al. · New England Journal of Medicine Open access 2 Nov 2011 2,213
33 Defining the role of common variation in the genomic and biological architecture of adult human height Andrew R. Wood et al. · Nature Genetics 446 authors 5 Oct 2014 2,114
34 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 Jonathan Kocarnik et al. · JAMA Oncology Open access601 authors 30 Dec 2021 2,100
35 Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease the Alzheimer's Disease Neuroimaging Initiative et al. · Nature Genetics Open access173 authors 3 Apr 2011 2,100
36 Genomewide Association Analysis of Coronary Artery Disease Nilesh J. Samani et al. · New England Journal of Medicine Open access 18 Jul 2007 2,062
37 Genome-wide association study identifies five new schizophrenia loci Stephan Ripke et al. · Nature Genetics Open access196 authors 18 Sep 2011 1,966
38 Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease Cardiogenics et al. · Nature Genetics Open access167 authors 6 Mar 2011 1,959
39 Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 21 Aug 2013 1,936
40 Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma Pranabashis Haldar, Christopher Edward Brightling, Beverley Hargadon et al. · New England Journal of Medicine Open access 4 Mar 2009 1,891
41 Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma Toni K. Choueiri et al. · New England Journal of Medicine Open access 3 Mar 2021 1,801
42 Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis The MAGIC investigators et al. · Nature Genetics Open access159 authors 27 Jun 2010 1,801
43 PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration Karel G.M. Moons, Robert F. Wolff, Richard D Riley et al. · Annals of Internal Medicine Open access 31 Dec 2018 1,730
44 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Robert Louis Coleman et al. · The Lancet Open access117 authors 12 Sep 2017 1,729
45 Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group Sally Fiona Barrington, Nabegh George Mikhaeel, Lale Kostakoğlu et al. · Journal of Clinical Oncology Open access 11 Aug 2014 1,681
46 Large-scale association analysis identifies new risk loci for coronary artery disease Panos Deloukas et al. · Nature Genetics Open access183 authors 2 Dec 2012 1,681
47 Coagulation abnormalities and thrombosis in patients with COVID-19 Marcel M Levi, Jecko V. Thachil, Toshiaki Iba et al. · The Lancet Haematology Open access 11 May 2020 1,623
48 The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee Elı́as Campo et al. · Blood Open access 2 Jun 2022 1,603
49 Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 Christina Fitzmaurice et al. · JAMA Oncology Open access153 authors 2 Jun 2018 1,550
50 Rare chromosomal deletions and duplications increase risk of schizophrenia Jennifer L. Stone et al. · Nature Open access 30 Jul 2008 1,516

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.